Keywords: Nycomed, Baxter, FDA, USA, TachoSil, Cardiovascular surgey

Nycomed and Baxter receive FDA approval to market TachoSil in the USA

Article | 07 April 2010

Print This

Swiss drugmaker Nycomed and its partner, USA-based Baxter International, have received the approval for TachoSil, a surgical patch, from the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in